Clinical Trials
533 trialsMK-4280A-007
Merck Sharp & Dohme LLC
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Emory University
SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study
SafeHeal Inc
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
SCORE
UNC Lineberger Comprehensive Cancer Center
Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
University of California, San Diego
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
Genentech, Inc.
LEAP-005
Merck Sharp & Dohme LLC
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
University of Wisconsin, Madison
NAUTICALCRC
Pierre Fabre Medicament
CHALLENGE
Canadian Cancer Trials Group
ANICCA
University of Birmingham
AXMUS-C
Imperial College London
AH-HA
Wake Forest University Health Sciences
Social Media and Cancer Screening Information
University of Utah
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
FOLFIRINOX-R
Institut du Cancer de Montpellier - Val d'Aurelle
Precision-Based Magnesium Trial
Vanderbilt University Medical Center
Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer
BeOne Medicines
RECITE
Amgen
PCSNaP
Abramson Cancer Center at Penn Medicine
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Roswell Park Cancer Institute
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Memorial Sloan Kettering Cancer Center
MK-7902-017
Merck Sharp & Dohme LLC
Screen to Save 2: Rural Cancer Screening Educational Intervention
Dartmouth-Hitchcock Medical Center
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
University of California, San Francisco
ALTAIR
National Cancer Center Hospital East
PeLear CCC
University of North Carolina, Chapel Hill
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
Milton S. Hershey Medical Center
DESTINY-CRC02
Daiichi Sankyo
KANSURVIVE
University of Kansas Medical Center
CAPSTAN CRC
Pierre Fabre Medicament
E-PROOF
Ohio State University Comprehensive Cancer Center
A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men
ISA Associates, Inc.
PREEMPT CRC
Freenome Holdings Inc.
CARES
Massachusetts General Hospital
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
Memorial Sloan Kettering Cancer Center
CheckMate 9N9
Bristol-Myers Squibb
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study
Merck Sharp & Dohme LLC
QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
NantCell, Inc.
Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors
Massachusetts General Hospital
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People
Alaska Native Tribal Health Consortium
ConsortiumIO
Vedanta Biosciences, Inc.
A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
Eisai Inc.
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Memorial Sloan Kettering Cancer Center
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Dartmouth-Hitchcock Medical Center
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
New Mexico Cancer Research Alliance
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
Sanofi